Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

125 Press Releases
DateTitleCompany
20 Mar 15 Biogen Idec Presents Positive Interim Results from Phase 1B Study of Investigational Alzheimer’s Disease Treatment Aducanumab (BIIB037) at 2015 AD/PD™ Conference Biogen Idec,
Published by
Business Wire
27 Feb 15 Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 ALPROLIX® Pediatric Study Biogen Idec,
Published by
Business Wire
27 Jan 15 CORRECTING AND REPLACING Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 29 2015 Biogen Idec,
Published by
Business Wire
12 Jan 15 Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals Biogen Idec,
Published by
Business Wire
09 Jan 15 Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research Biogen Idec,
Published by
Business Wire
08 Jan 15 Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis Biogen Idec,
Published by
Business Wire
23 Dec 14 Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 28 2015 Biogen Idec,
Published by
Business Wire
23 Oct 14 Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases Biogen Idec,
Published by
Business Wire
15 Oct 14 Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals Biogen Idec,
Published by
Business Wire
08 Oct 14 CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22 2014 Biogen Idec,
Published by
Business Wire
26 Sep 14 Biogen Idec To Report Third Quarter 2014 Financial Results on October 22 2014 Biogen Idec,
Published by
Business Wire
23 Sep 14 Biogen Idec Named Global Biotechnology Industry Leader on Dow Jones Sustainability World Index Biogen Idec,
Published by
Business Wire
23 Sep 14 Olivier Danos Joins Biogen Idec as Senior Vice President Gene Therapy Biogen Idec,
Published by
Business Wire
26 Aug 14 Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub Biogen Idec,
Published by
Business Wire
21 Aug 14 Biogen Idec Names Adriana Karaboutis EVP Technology and Business Solutions Biogen Idec,
Published by
Business Wire
16 Jul 14 Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple Sclerosis (MS) Biogen Idec,
Published by
Business Wire
28 May 14 Biogen Idec Announces Official Partnership with Sailing Sclerosis’ “Oceans of Hope” to Globally Change Perceptions of MS Biogen Idec,
Published by
Business Wire
12 May 14 Richard A. Rudick Joins Biogen Idec as Vice President, Development Sciences, Value-Based Medicine Biogen Idec,
Published by
Business Wire
04 Sep 13 Biogen Idec Foundation Awards $250,000 Grant to Citizen Schools to Invest in Science Education in Massachusetts and North Carolina Biogen Idec,
Published by
Business Wire
17 Dec 13 Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in Europe Biogen Idec,
Published by
Business Wire
24 May 13 Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis Biogen Idec,
Published by
Business Wire
15 Jan 14 Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis Biogen Idec,
Published by
Business Wire
15 Feb 14 William D. Young To Retire From Biogen Idec’s Board of Directors Biogen Idec,
Published by
Business Wire
20 Sep 13 Biogen Idec Employees Participate in Third Annual “Care Deeply Volunteer Day” Biogen Idec,
Published by
Business Wire
24 Sep 13 Biogen Idec Becomes First U.S.-Based Biotech Named to Dow Jones Sustainability World Index Biogen Idec,
Published by
Business Wire
22 Nov 13 CHMP Determines Dimethyl Fumarate in TECFIDERA® to be a New Active Substance in the European Union Biogen Idec,
Published by
Business Wire
02 Dec 13 Biogen Idec Receives Notification from FDA of PDUFA Date Extension for ALPROLIX™ Biogen Idec,
Published by
Business Wire
19 Jul 13 US and EU Regulatory Authorities Accept PLEGRIDY™ (peginterferon beta-1a) Marketing Applications for Review Biogen Idec,
Published by
Business Wire
10 Apr 14 Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer Biogen Idec,
Published by
Business Wire
18 Mar 14 Biogen Idec Receives Notification of PDUFA Date Extension for Plegridy™ (Peginterferon Beta-1a) Biogen Idec,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.